Rathyronine

Rathyronine

SCHEMBL123365

NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

THRATHRB

The experimentally established mechanism targets of Rathyronine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB known ✓ P10828 14/20 1.00
THRA known ✓ P10827 10/20 1.00
LMNA P02545 6/20 1.00
MEN1 O00255 6/20 1.00
KMT2A Q03164 6/20 1.00
PCNA P12004 4/20 1.00
PPARG P37231 4/20 1.00
ABCB11 O95342 2/20 1.00
GABRA1 P14867 2/20 1.00
GABRA2 P47869 2/20 1.00
GABRB2 P47870 2/20 1.00
CYP2D6 P10635 1/20 1.00
TSHR P16473 1/20 1.00
GABRP O00591 1/20 1.00
GABRD O14764 1/20 1.00
F2 P00734 1/20 1.00
GABRB1 P18505 1/20 1.00
GABRG2 P18507 1/20 1.00
GABRB3 P28472 1/20 1.00
ADORA1 P30542 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Detrothyronine SCHEMBL29651848 1.00 THRB (1.00) THRBTHRALMNAMEN1KMT2A
Detrothyronine SCHEMBL29383803 1.00 THRB (1.00) THRBTHRALMNAMEN1KMT2A
Liothyronine SCHEMBL3287278 1.00 THRB (1.00) THRBTHRALMNAMEN1KMT2A
Liothyronine SCHEMBL29390909 1.00 THRB (1.00) THRBTHRALMNAMEN1KMT2A
Liothyronine SCHEMBL8300 1.00 THRB (1.00) THRBTHRALMNAMEN1KMT2A
Detrothyronine SCHEMBL8301 1.00 THRB (1.00) THRBTHRALMNAMEN1KMT2A
Detrothyronine SCHEMBL4608153 0.99 THRB (0.97) THRBTHRALMNAMEN1KMT2A
Liothyronine SCHEMBL2679283 0.99 THRB (0.97) THRBTHRALMNAMEN1KMT2A
Detrothyronine SCHEMBL21749451 0.99 THRB (0.97) THRBTHRALMNAMEN1KMT2A
Liothyronine SCHEMBL438744 0.99 THRB (0.97) THRBTHRALMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2517 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085899-A1 PRODUCTION OF SALIVARY GLAND EPITHELIAL PROGENITORS AND SALIVARY GLAND CELL ORGANOIDS FOR REGENERATIVE MEDICINE AND DRUG TESTING PURPOSES THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2025-04-24 WO claimed
EP-3522825-B1 IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE TITAN PHARMACEUTICALS INC (US) 2023-06-07 EP claimed
EP-3908272-B1 L-TRIIODOTHYRONINE (T3) FOR USE IN LIMITING MICROVASCULAR OBSTRUCTION UNI PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S A (GR) 2023-03-22 EP claimed
EP-4138810-A1 PHARMACEUTICAL COMPOSITION COMPRISING L-TRIIODOTHYRONINE (T3) FOR USE IN THE TREATMENT OF TISSUE HYPOXEMIA AND SEPSIS Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. (GR) 2023-03-01 EP claimed
US-20220265775-A1 COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION UNIV MINNESOTA (US) 2022-08-25 US claimed
EP-3955954-A1 COMBINATION THERAPY FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES NGM Biopharmaceuticals, Inc. (US) 2022-02-23 EP claimed
US-20200390858-A1 Combination Therapy for Modulating Bile Acid Homeostasis and Treatment of Bile Acid Disorders and Diseases NGM BIOPHARMACEUTICALS, INC. 2020-12-17 US claimed
WO-2020214753-A1 COMBINATION THERAPY FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES NGM BIOPHARMACEUTICALS, INC. (US) 2020-10-22 WO claimed
US-20200222348-A1 BIMODAL MODIFIED RELEASE COMPOSITIONS FOR CANCER TREATMENT MUSLI THYROPEUTICS LTD. (IL) 2020-07-16 US claimed
US-10053445-B2 Photocleavable chemical inducers of dimerization (CID) and methods of use CHILDREN'S MEDICAL CENTER CORPORATION (US) 2018-08-21 US claimed
US-4711855-A Derivatives of 3,5,3-triiodothyronine CIBA CORNING DIAGNOSTICS CORP. (US) 1987-12-08 US claimed
US-4673691-A CONCURRENT ADMINISTRATION OF 2,4-DINITROPHENOL AND 3,5,3*-TRI IODOTHYRONINE Bachynsky, Nicholas (US) 1987-06-16 US claimed
EP-0165669-A1 Improved method of measuring free ligand Corning Glass Works (US) 1985-12-27 EP claimed
EP-0093653-B1 PROCESS FOR THE PREPARATION OF IODO-THYRONINES AND IODO-THYROACETIC ACIDS BY ELECTROCHEMICAL REDUCTION AT A CONTROLLED POTENTIAL SPIRAL Société à responsabilité limitée dite : (FR) 1985-07-10 EP claimed
US-4490221-A Process for preparing iodothyronines and iodothyroacetic acids by electrochemical reduction at controlled potential SPIRAL SOCIETE A RESPONSABILITE LIMITEE DITE (FR) 1984-12-25 US claimed
EP-0049860-B1 PROCESS FOR THE PREPARATION OF REACTIVE THYROID GLAND HORMONES T3 AND T4 DERIVATIVES THAT ARE CAPABLE OF COUPLING, AND THEIR USE Roche Diagnostics GmbH (DE) 1984-10-03 EP claimed
US-4423227-A SILYLATION, ACYLATION BOEHRINGER MANNHEIM GMBH (DE) 1983-12-27 US claimed
US-4410633-A IMMUNOASSAY CORNING GLASS WORKS (US) 1983-10-18 US claimed
EP-0046270-A1 Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them INTERx RESEARCH CORPORATION (US) 1982-02-24 EP claimed
US-4299812-A Immunoassay of thyroxine in neonates using dried blood samples DIAGNOSTIC PRODUCTS CORP. (US) 1981-11-10 US claimed